Detection of lymphocyte Fc gamma receptor-blocking factors by the EA rosette inhibition assay. Refinement of the conventional method and development of a novel flow-cytometric assay.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8429230)

Published in J Immunol Methods on February 03, 1993

Authors

G P Sandilands1, M R Greer, S E Chisholm, I C McKay, I Downie, M A McMillan, R N MacSween

Author Affiliations

1: University Department of Pathology, Western Infirmary, Glasgow, Scotland, UK.

Articles by these authors

(truncated to the top 100)

Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11

A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65

Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43

Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet (1988) 2.10

Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01

Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol (1974) 2.00

Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet (1999) 1.80

Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut (2000) 1.78

Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77

Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin Infect Dis (2001) 1.72

Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71

Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69

Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69

Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum (2000) 1.65

Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol (1979) 1.61

Studies on pregnancy-associated globulin. Clin Exp Immunol (1973) 1.50

Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol (1973) 1.47

Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant (1997) 1.47

A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis (1997) 1.44

Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41

Histologic spectrum of alcoholic liver disease. Semin Liver Dis (1986) 1.33

Antibodies to alcohol-altered hepatocytes in patients with alcoholic liver disease. Lancet (1981) 1.29

Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol (1981) 1.27

Angiosarcoma of the liver in Great Britain, 1963-73. Br Med J (1977) 1.26

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine. Vaccine (2002) 1.25

Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin Exp Immunol (1973) 1.25

A clinicopathological review of 100 cases of primary malignant tumours of the liver. J Clin Pathol (1974) 1.21

Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. J Pathol (1986) 1.19

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Dig Dis Sci (1999) 1.17

Immunosuppression in sclerosing peritonitis. Adv Perit Dial (1993) 1.15

Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling. Histopathology (1990) 1.13

Post-infantile giant cell hepatitis: histological and immunohistochemical study. J Clin Pathol (1994) 1.12

Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest (1989) 1.12

Haemangio-endothelial sarcoma of the liver. J Pathol (1973) 1.09

A comparative study of some commercially available tests for rheumatoid factor. J Clin Pathol (1974) 1.09

The T1799A point mutation is present in posterior uveal melanoma. Br J Cancer (2008) 1.07

Liver membrane antibodies in alcoholic liver disease. II. Antibodies to ethanol-altered hepatocytes. J Clin Pathol (1983) 1.06

Proceedings: Evidence of impaired cell mediated immunity in the seronegative arthritides. Ann Rheum Dis (1975) 1.05

Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol (2006) 1.03

Jaundice associated with the use of benoxaprofen. Lancet (1982) 1.03

Early graft function and patient survival following cadaveric renal transplantation. Kidney Int (1999) 1.02

Immune-complex inhibition of lymphocyte Fc gamma-receptors in primary biliary cirrhosis: a possible immunomodulatory mechanism. Lancet (1980) 1.01

Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver (1999) 1.00

Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00

Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clin Exp Immunol (1973) 0.99

The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Clin Exp Immunol (1976) 0.99

Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver. Hepatology (1989) 0.98

Antinuclear factors in synovial fluids. Lancet (1967) 0.97

Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle. J Clin Pathol (2002) 0.97

Plasma-dependent chemotaxis of macrophages towards mycobacterium tuberculosis and other organisms. Immunology (1972) 0.96

The parietal podocyte: a study of the vascular pole of the human glomerulus. Kidney Int (1992) 0.95

Experimental studies on the hepatic effects of tetracycline. Br J Exp Pathol (1967) 0.95

Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg Oncol (1996) 0.94

An auto-antibody profile in alopecia totalis and diffuse alopecia. Br J Dermatol (1976) 0.93

The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology (1976) 0.93

Heterogeneity of rat peritoneal and alveolar macrophage populations: spontaneous rosette formation using sheep and chicken red blood cells. J Reticuloendothel Soc (1978) 0.93

Immune mechanisms in alcoholic liver disease. J Clin Lab Immunol (1982) 0.93

Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. Am J Clin Pathol (2001) 0.92

The molecular requirements for chemotactic attraction of leucocytes by proteins. Studies of proteins with synthetic side groups. Eur J Immunol (1972) 0.91

Hepatobiliary complications in chronic pancreatitis. Gut (1989) 0.91

Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant (1998) 0.90

In-vitro reactions of lymphocytes in rheumatoid arthritis and other rheumatic diseases. Ann Rheum Dis (1979) 0.90

Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation. Lab Invest (1969) 0.90

Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies. J Pathol (1989) 0.90

Serum protein levels in primary biliary cirrhosis. J Clin Pathol (1972) 0.89

Recognition in leucocyte chemotaxis. Studies with structurally modified proteins. Antibiot Chemother (1971) (1974) 0.89

Basement membrane peptides as markers of liver disease in chronic hepatitis C. J Hepatol (2000) 0.89

The cellular pathology of primary biliary cirrhosis. Mol Aspects Med (1985) 0.89

Long-term treatment of Hashimoto's thyroiditis with thyroxine. Lancet (1972) 0.89

Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol (1975) 0.88

Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye (Lond) (2005) 0.88

The glomerular peripolar cell: a review. Histol Histopathol (1991) 0.88

Breast cancer in women with primary biliary cirrhosis. Br Med J (Clin Res Ed) (1985) 0.87

Foetal cerebellar tissue in an ovarian teratoma. J Pathol Bacteriol (1968) 0.87

Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis. Clin Radiol (1991) 0.87

Hepatitis virus infection and liver disease in injecting drug users who died suddenly. J Clin Pathol (1996) 0.87

Liver disease in rheumatoid arthritis. Scott Med J (1980) 0.87

Comparison of Fc gamma-receptors isolated from normal human serum and peripheral blood lymphocytes. J Clin Lab Immunol (1984) 0.87

Implant-retained nasal prosthesis for reconstruction of large rhinectomy defects: the Salisbury experience. Int J Oral Maxillofac Surg (2010) 0.86

The IgE and IgG antibody responses to aerosols of Nephrops norvegicus (prawn) antigens: the association with clinical hypersensitivity and with cigarette smoking. Clin Exp Immunol (1994) 0.86

The chemotactic activity of native and denatured serum albumin. Int Arch Allergy Appl Immunol (1971) 0.86

Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: relationship to histological features. Dig Dis Sci (1998) 0.86

Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class. Gut (1982) 0.86

Iron metabolism by reticuloendothelial cells. In vitro uptake of transferrin-bound iron by rat and rabbit cells. Lab Invest (1969) 0.86

Effect of hyperbaric oxyhelium gas on response of bacteria to antimicrobial agents in vitro. Antimicrob Agents Chemother (1984) 0.86

The use of collagen or fibrin gels for the assay of human neutrophil chemotaxis. J Immunol Methods (1985) 0.85

Alcohol and liver injury: genetic and immunologic factors. Acta Med Scand Suppl (1985) 0.85

Serum Fc gamma-receptor-like molecules in primary biliary cirrhosis: a possible immunoregulatory mechanism. Immunology (1984) 0.85

A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides. Clin Exp Immunol (1968) 0.85

The peripolar cell: a distinctive cell type in the mammalian glomerulus. Morphological evidence from a study of sheep. J Anat (1990) 0.85

Interstitial nephritis and primary biliary cirrhosis: a new association? Clin Nephrol (1987) 0.85

Arthritis and primary biliary cirrhosis. Br Med J (1977) 0.84

Occult expression of CD32 (Fc gamma RII) in normal human peripheral blood mononuclear cells. Immunology (1995) 0.84

Bilateral uveal melanoma: a series of four cases. Eye (Lond) (2003) 0.84

Alcohol and cancer. Br Med Bull (1982) 0.84

Identification of a novel Fcalpha receptor expressed by human mesangial cells. Kidney Int (2000) 0.83

Correlation between high-molecular-weight Fc gamma-receptor-blocking factors in serum and renal allograft survival. Transplantation (1987) 0.83

Bile duct proliferation--its true significance? Histopathology (1993) 0.83